Imanis Life Sciences is a biotechnology company focused on providing non-invasive imaging solutions and specializing in oncolytic virotherapy. The company offers a range of products and services, including custom virus and cell solutions, virus assays, and contract research to support the development of oncolytic virus therapies, gene and cell therapies, regenerative medicines, and vaccines. Their mission is to advance scientific excellence in these areas to facilitate groundbreaking medical research and treatments.
Imanis Life Sciences has made significant strides in the biotechnology sector by developing innovative tools and methods that enhance the efficiency and effectiveness of medical research. Their expertise in engineering custom cell lines and validating transgene expression has positioned them as a valuable partner for researchers and pharmaceutical companies. Through their contributions, Imanis has had a notable impact on the advancement of therapies that address critical medical needs.
